Nebraska Cancer Specialist/Missouri Valley Cancer Consortium — Omaha, Nebraska

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium is a clinical research site located in Omaha, Nebraska, United States 68106.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD), Non-small Cell Lung Cancer (NSCLC).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialist/Missouri Valley Cancer Consortium?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialist/Missouri Valley Cancer Consortium conducted?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD), Non-small Cell Lung Cancer (NSCLC).

Is Nebraska Cancer Specialist/Missouri Valley Cancer Consortium accredited by Crixeo Health?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialist/Missouri Valley Cancer Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.